BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 31727015)

  • 1. Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists.
    Correll CU; Brevig T; Brain C
    BMC Psychiatry; 2019 Nov; 19(1):362. PubMed ID: 31727015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis.
    Mizuno Y; McCutcheon RA; Brugger SP; Howes OD
    Neuropsychopharmacology; 2020 Mar; 45(4):622-631. PubMed ID: 31766049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists.
    Correll CU; Brevig T; Brain C
    Neuropsychiatr Dis Treat; 2019; 15():3461-3473. PubMed ID: 31908461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of Treatment-Resistant and Clozapine-Resistant Schizophrenia: A 12-Year Follow-up Study of First-Episode Schizophrenia-Spectrum Disorders.
    Chan SKW; Chan HYV; Honer WG; Bastiampillai T; Suen YN; Yeung WS; Lam M; Lee WK; Ng RMK; Hui CLM; Chang WC; Lee EHM; Chen EYH
    Schizophr Bull; 2021 Mar; 47(2):485-494. PubMed ID: 33043960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experiences, attitudes, and perceptions of caregivers of individuals with treatment-resistant schizophrenia: a qualitative study.
    Brain C; Kymes S; DiBenedetti DB; Brevig T; Velligan DI
    BMC Psychiatry; 2018 Aug; 18(1):253. PubMed ID: 30103719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-Resistant Schizophrenia: Definition, Predictors, and Therapy Options.
    Correll CU; Howes OD
    J Clin Psychiatry; 2021 Sep; 82(5):. PubMed ID: 34496461
    [No Abstract]   [Full Text] [Related]  

  • 7. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance abuse and the management of medication nonadherence in schizophrenia.
    Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
    J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual Atypical Antipsychotics in Treatment-Resistant Schizophrenia: A Correctional Case Report and Review of Literature.
    Warnick JA; Gifeisman RI; Joshi KP; Roe SA; Hiciano RA; Conroy CP; Zahedi S
    J Correct Health Care; 2024 Jun; 30(3):167-171. PubMed ID: 38563618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychiatrists' decision making and monitoring of antipsychotic prescription for elderly schizophrenia patients].
    Jalenques I; Ortega V; Legrand G; Auclair C
    Encephale; 2016 Apr; 42(2):124-9. PubMed ID: 26796558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iranian psychiatrists' attitude towards clozapine use for patients with treatment-resistant schizophrenia: a nationwide survey.
    Rezaie L; Nazari A; Safari-Faramani R; Shohaimi S; Khazaie H
    BMC Psychiatry; 2022 Aug; 22(1):534. PubMed ID: 35933353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of electroconvulsive therapy in patients with treatment resistant schizophrenia: A retrospective study.
    Grover S; Chakrabarti S; Hazari N; Avasthi A
    Psychiatry Res; 2017 Mar; 249():349-353. PubMed ID: 28152470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose lamotrigine augmentation therapy improves residual symptoms in treatment-resistant schizophrenia: a report of five cases.
    Ohnuma T; Takebayashi Y; Higashiyama R; Shibata N; Arai H
    Asia Pac Psychiatry; 2013 Dec; 5(4):336-43. PubMed ID: 24591092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guideline for the pharmacotherapy of treatment-resistant schizophrenia. Royal College of Psychiatrists of Thailand.
    Disayavanish C; Srisurapanont M; Udomratn P; Disayavanish P; Kasantikul D; Netrakom P; Ngamtipwatthana T; Phornchirasilp S; Rangseekajee P; Samuthrsindh P; Sukanich P; Thiam-Kaew K; Visanuyothin T
    J Med Assoc Thai; 2000 Jun; 83(6):579-89. PubMed ID: 10932483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical predictors of therapeutic response to clozapine in a sample of Turkish patients with treatment-resistant schizophrenia.
    Semiz UB; Cetin M; Basoglu C; Ebrinc S; Uzun O; Herken H; Balibey H; Algul A; Ates A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1330-6. PubMed ID: 17618026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ever-growing case for clozapine in the treatment of schizophrenia: an obligation for psychiatrists and psychiatry.
    Bittner RA; Reif A; Qubad M
    Curr Opin Psychiatry; 2023 Jul; 36(4):327-336. PubMed ID: 37222196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.
    Ochi S; Tagata H; Hasegawa N; Yasui-Furukori N; Iga JI; Kashiwagi H; Kodaka F; Komatsu H; Tsuboi T; Tokutani A; Numata S; Ichihashi K; Onitsuka T; Muraoka H; Iida H; Ohi K; Atake K; Kishimoto T; Hori H; Takaesu Y; Takeshima M; Usami M; Makinodan M; Hashimoto N; Fujimoto M; Furihata R; Nagasawa T; Yamada H; Matsumoto J; Miura K; Kido M; Hishimoto A; Ueno SI; Watanabe K; Inada K; Hashimoto R
    Int J Neuropsychopharmacol; 2022 Oct; 25(10):818-826. PubMed ID: 35723038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia.
    de Bartolomeis A; Ciccarelli M; Vellucci L; Fornaro M; Iasevoli F; Barone A
    Expert Opin Pharmacother; 2022 Dec; 23(18):2035-2052. PubMed ID: 36368055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.